Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.50 ($0.02), with a volume of 2272402 shares trading hands. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Price Performance
The business’s 50-day moving average price is GBX 1.74 and its two-hundred day moving average price is GBX 1.84. The firm has a market cap of £5.91 million, a price-to-earnings ratio of -2,093.22 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Stock Splits, Do They Really Impact Investors?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Expert Stock Trading Psychology Tips
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
